Eyenovia

$3.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (+1.47%) Today

+$0.05 (+1.45%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell Eyenovia and other stocks, options, and ETFs commission-free!

About EYEN

Eyenovia, Inc. Common Stock, also called Eyenovia, is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY. The listed name for EYEN is Eyenovia, Inc. Common Stock.

CEO

Sean Ianchulev

Employees

Headquarters

New York, New York

Founded

2014

Market Cap

85.85M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

126.57K

High Today

$3.58

Low Today

$3.34

Open Price

$3.43

Volume

245.35K

52 Week High

$6.92

52 Week Low

$1.11

Collections

Research And Development

Therapy

Pharmaceutical

2018 IPO

EYEN Earnings

-$0.51

-$0.34

-$0.17

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 24, After Hours